James R Meyers
CIK 1387521 · EVP Worldwide Commercial Ops · last filed 2026-06-22
James R Meyers is an EVP Worldwide Commercial Ops who has filed 40 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CTMX, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$14.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $18.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.30M
5
40
-$14.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTMX | Director | — | $3.37 | — | $0 | 9 | 2026-06-22 |
| VERA | Director | — | $32.02 | — | $0 | 2 | 2026-05-26 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 99,600 | $0.18 | $17.7K | $0 | 8 | 2025-06-16 |
| ABUS | Director | — | $4.54 | — | $0 | 7 | 2024-05-24 |
| GILD | EVP Worldwide Commercial Ops | 139,865 | $130.86 | $18.30M | -$14.19M | 14 | 2018-02-23 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2026-05-26 | VERA | Grant (A) | — | $0 | EDGAR |
| 2025-11-26 | VERA | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2025-06-13 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-05-24 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +13,900 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.